Loss of Immunoreactivity for Human Calmodulin-Like Protein is an Early Event in Breast Cancer Development

Neoplasia

Volumn 1, Issue 3, 1999, Pages 220-225

  Rogers, Michael S ^a   Foley, Margaret A ^a,b   Crotty, Thomas B ^a,c   Hartmann, Lynn C ^a   Ingle, James N ^a   Roche, Patrick C ^a   Strehler, Emanuel E ^a,d  

^a MAYO CLINIC CANCER CENTER   (United States)

^b ABBOTT LABORATORIES   (United States)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d MAYO CLINIC   (United States)

Author keywords

Breast cancer; Calmodulin like protein; Epithelial differentiation; Immunohistochemistry; Tumorigenesis

Indexed keywords

CALMODULIN;

ANIMAL; ARTICLE; BREAST TUMOR; CHEMISTRY; DOWN REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RABBIT;

ANIMALS; BREAST NEOPLASMS; CALMODULIN; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; RABBITS;

EID: 0033170851     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900029     Document Type: Article

References (25)

1. Boring CC, Squires TS, Tong T, and Montgomery S (1994). Cancer statistics. CA Cancer J Clin 44, 7-26.
2. Walker RA, and Varley JM (1993). The molecular pathology of human breast cancer. Cancer Surv 16, 31-57.
3. Wolman SR, Heppner GH, and Wolman E (1997). New directions in breast cancer research. FASEB J 11, 535-543.
4. de la Chapelle A, and Peltomäki P (1998). The genetics of hereditary common cancers. Curr Op Genetics & Development 8, 298-303.
5. Rasmussen CD, and Means AR (1987). Calmodulin is involved in regulation of cell proliferation. EMBO J 6, 3961-3968.
6. 1 and mitosis. EMBO J 8, 73-82.
7. Lu KP, and Means AR (1993). Regulation of the cell cycle by calcium and calmodulin. Endocrine Rev 14, 40-58.
8. Takemoto D, and Jilka K (1983). Increased content of calmodulin in human leukemic cells. Leukemia Res 7, 97-100.
9. Wei J-W, and Hickie RA (1981). Increased content of calmodulin in Morris hepatoma 5123 tc (h). Biochim Biophys Res Commun 256, 1562-1568.
10. Takuwa N, Zhou W, and Takuwa Y (1995). Calcium, calmodulin and cell cycle progression. Cell Signalling 7, 93-104.
11. Yaswen P, Smoll A, Peehl DM, Trask DK, Sager R, and Stampfer MR (1990). Down-regulation of a calmodulin-related gene during transformation of human mammary epithelial cells. Proc Natl Acad. Sci USA 87, 7360-7364.
12. Lee SW, Tomasetto C, Swisshelm K, Keyomarsi K, and Sager R (1992). Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad Sci USA 89, 2504-2508.
13. Schafer BW, and Heizmann CW (1996). The S100 family of EF-hand calcium-binding proteins: functions and pathology. TIBS 21, 134-140.
14. Rogers MS, and Strehler EE (1996). Calmodulin-like proteins. In Guidebook to Calcium-Binding Proteins. M Celio, Ed. Oxford University Press, Oxford, UK, pp. 41-43.
15. Koller M, and Strehler EE (1988). Characterization of an intronless human calmodulin-like pseudogene. FEBS Lett 239, 121-128.
16. Rhyner JA, Koller M, Durussel-Gerber I, Cox JA, and Strehler EE (1992). Characterization of the human calmodulin-like protein expressed in Escherichia coli. Biochemistry 31, 12826-12832.
17. Edman CF, George SE, Means AR, Schulman H, and Yaswen P (1994). Selective activation and inhibition of calmodulin-dependent enzymes by a calmodulin-like protein found in human epithelial cells. Eur J Biochem 226, 725-730.
18. Yaswen P, Smoll A, Hosoda J, Parry G, and Stampfer MR (1992). Protein product of a human intronless calmodulin-like gene shows tissue-specific expression and reduced abundance in transformed cells. Cell Growth Differentiation 3, 335-345.
19. 13C resonances and secondary structure of human calmodulin-like protein determined by NMR spectroscopy. Protein Sci 7, 2421-2430.
20. Hsu S-M, Raine L, and Fanger H (1981). Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29, 577-580.
21. Hartmann LC, Ingle JN, Wold LE, Farr GH Jr, Grill JP, Su JQ, Maihle NJ, Krook JE, Witzig TE, and Roche PC (1994). Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol. Cancer 74, 2956-2963.
22. Harris E, Yaswen P, and Thorner J (1995). Gain-of-function mutations in a human calmodulin-like protein identify residues critical for calmodulin action in yeast. Mol Gen Genet 247, 137-147.
23. Hickie RA, Graham MJ, Buckmeier JA, and Meyskens FL, Jr. (1992). Comparison of calmodulin gene expression in human neonatal melanocytes and metastatic melanoma cell lines. J Invest Dermatol 99, 764-773.
24. Baylin SB, Herman JG, Graff JR, Vertino PM, and Issa JP (1998). Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72, 141-196.
25. Wicki R, Franz C, Scholl FA, Heizmann CW, and Schafer BW (1997). Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium 22, 243-254.